The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract

Current Pharmaceutical Biotechnology

Volumn 2, Issue 2, 2001, Pages 187-200

  Joshi, S S ^a,c   Kuszynski, C A ^a   Bagchi, D ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; IDARUBICIN; PROANTHOCYANIDIN; PROTEIN BCL 2; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DAMAGE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DIET SUPPLEMENTATION; DOWN REGULATION; EXPOSURE; FEMALE; GRAPE; HEALTH; LIVER CELL; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUTRITION; ONCOGENE C MYC; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTHOCYANINS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIOXIDANTS; APOPTOSIS; CELLS, CULTURED; CYCLOPHOSPHAMIDE; FEMALE; GENES, BCL-2; GENES, MYC; GENES, P53; HUMANS; IDARUBICIN; MICE; PHYTOTHERAPY; PROANTHOCYANIDINS; ROSALES; SEEDS;

ANIMALIA; VITIS SP.;

EID: 0035005704     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389201013378725     Document Type: Article

References (42)